Tuesday, February 4, 2014

Case Report on Genetic Diagnosis of Fatal Disorder in Embryos Before Pregnancy

JAMA Neurology Releases for February 03, 2014 > Print

 

 

Case Report on Genetic Diagnosis of Fatal Disorder in Embryos Before Pregnancy

 

 

EMBARGOED FOR RELEASE: 3 P.M. (CT), MONDAY, February 3, 2014

 

Media Advisory: To contact corresponding author Ilan Tur-Kaspa, M.D., call 312-493-3068 or email iturkaspa@gmail.com or DrTK@infertilityIHR.com and for corresponding author Murali Doraiswamy, M.B.B.S., F. R.C.P., call Rachel Harrison at 919-419-5069 or email rachel.harrison@duke.edu.

 

 

 

JAMA Neurology Study Highlights

 

 

 

Genetic testing of embryos for a fatal inherited neurodegenerative disorder allowed a woman to selectively implant two mutation-free embryos and conceive healthy twins, what researchers call the first case of in vitro fertilization (IVF) with preimplantation genetic diagnosis (PGD) to prevent genetic prion disease in children, according to a case report by Alice Uflacker, M.D., of Duke University, Durham, N.C., and colleagues.

 

 

 

The 27-year-old woman is a carrier of the F198S mutation for Gerstmann-Sträussler-Sheinker syndrome (GSS), a fatal neurodegenerative disorder linked to abnormal prion protein folding. There is no known cure and the illness is fatal, according to the case background.

 

 

 

During IVF treatment, 12 of the 14 oocytes (egg cells) retrieved from the woman were fertilized and six mutation-free embryos were identified. The patient opted to have two embryos transferred and three remaining viable embryos frozen through cryopreservation.

 

 

 

The two embryos successfully implanted and the woman delivered twins by Cesarean section at 33 weeks and five days of gestation. By age 27 months, the twins had reached communication, social and emotional developmental milestones on schedule.

 

 

 

“IVF with PGD is a viable option for couples who wish to avoid passing the disease to their offspring. Neurologists should be aware of PGD to be able to better consult at-risk families on their reproductive choices,” the authors conclude.

 

 (JAMA Neurol. Published online February 3, 2014. doi:10.1001/.jamaneurol.2013.5884. Available pre-embargo to the media at http://media.jamanetwork.com.)

 

 

 

Editor’s Note: Authors made conflict of interest and funding disclosures. Please see the articles for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

 

# # #

 

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email mediarelations@jamanetwork.org.

 


 

 

Thursday, January 30, 2014

 

Evidence in Sheep for Pre-Natal Transmission of Scrapie to Lambs from Infected Mothers

 


 

 

Sunday, January 19, 2014

 

*** National Prion Disease Pathology Surveillance Center Cases Examined1 as of January 8, 2014 ***

 


 

 

Monday, February 03, 2014

 

CREUTZFELDT-JAKOB DISEASE T.S.E. PRION U.K. UPDATE As at 3rd February 2014

 


 

 

 

TSS

No comments:

Post a Comment